Muhammad Younus, MD, PhD

Pfizer Inc USA

Poster(s):

• (249) Validation of Diagnoses of Hepatic Disorders in Users of Systemic Antifungal Medication in Sweden
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT

• (285) Real-world Data Evaluating Safety, Effectiveness and Dosing of Dalteparin for the Treatment of Venous Thromboembolism (VTE) in Neonates Aged 0 to 28 days
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT

• (296) A Post Authorization Safety Study of Long-Term Voriconazole Use in Sweden: A Population Based Cohort Study
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT